RXN

1 member of Congress has disclosed 4 trades in RXN (RXN) via STOCK Act filings. The most recent disclosure was a sale by Gilbert Cisneros on 22 July 2020. Aggregate disclosed activity totals roughly $16K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for RXN
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for RXN

4 transactions
Compliance: 100%
Gilbert Cisneros22 Jul 202019 Aug 2020SaleStock$1,001 - $15,000N/A
Gilbert Cisneros21 Jul 202019 Aug 2020SaleStock$1,001 - $15,000N/A
Gilbert Cisneros9 Apr 201914 May 2019PurchaseStock$1,001 - $15,000N/A
Gilbert Cisneros15 Mar 201916 Apr 2019PurchaseStock$1,001 - $15,000N/A

No overview data available for this stock

Earnings

Recent Quarters

Q3 202126 Oct
EPS-
Q2 202120 Jul
EPS$0.58
Beat 16.0%
Q1 202127 Apr
EPS$0.47
Beat 4.4%
Q4 202016 Feb
EPS$0.39
Beat 2.6%
Q3 202027 Oct
EPS$0.47
Beat 27.0%
Q2 202028 Jul
EPS$0.36
Beat 12.5%
Q1 202012 May
EPS$0.55
Beat 10.0%
Q4 201928 Jan
EPS$0.48
Beat 14.3%
Q3 201929 Oct
EPS$0.51
Beat 8.5%
Q2 201930 Jul
EPS$0.48
Beat 11.6%
Q1 20198 May
EPS$0.51
Beat 8.5%
Q4 201830 Jan
EPS$0.47
Beat 17.5%
Q3 201830 Oct
EPS$0.46
Beat 9.5%
Q2 201830 Jul
EPS$0.41
Beat 13.9%
Q1 201814 May
EPS$0.42
Beat 7.7%
Q4 201731 Jan
EPS$0.37
Beat 32.1%
Q3 20171 Nov
EPS$0.32
Beat 0.0%
Q2 20172 Aug
EPS$0.27
Beat 3.9%
Q1 201717 May
EPS$0.35
Beat 6.1%
Q4 20161 Feb
EPS$0.25
Beat 0.0%
Q3 20162 Nov
EPS$0.38
Beat 0.0%
Q2 20161 Aug
EPS$0.35
Beat 16.7%
Q1 201619 May
EPS$0.37
Beat 2.8%
Q4 20152 Feb
EPS$0.38
Beat 5.6%
Q3 20153 Nov
EPS$0.34
Beat 6.3%
Q2 20154 Aug
EPS$0.30
Beat 7.1%
Q1 201520 May
EPS$0.54
Beat 0.0%
Q4 20144 Feb
EPS$0.32
Beat 3.2%
Q3 20146 Nov
EPS$0.40
Beat 0.0%
Q2 20146 Aug
EPS$0.26
Beat 4.0%
Q1 201421 May
EPS$0.50
Beat 6.4%
Q4 201328 Jan
EPS$0.34
Beat 6.3%
Q3 201324 Oct
EPS$0.31
Beat 19.2%
Q2 20132 Aug
EPS$0.24
Beat 9.1%
Q1 201321 May
EPS$0.32
Beat 3.2%
Q4 201211 Feb
EPS$0.19
Miss 5.0%
Q3 201229 Dec
EPS$0.09
Q3 20127 Nov
EPS$0.24
Beat 20.0%
Q2 201229 Sept
EPS$0.19
Q2 20121 Aug
EPS$0.22
Miss 8.3%
Q1 201230 Jun
EPS$-0.02
Q4 201131 Mar
EPS$0.13
Q3 201131 Dec
EPS$0.08
Q2 201130 Sept
EPS$0.06
Q1 201130 Jun
EPS$0.16
Q4 201031 Mar
EPS$0.04
Q3 201031 Dec
EPS$0.01
Q2 201030 Sept
EPS$0.30
Q1 201030 Jun
EPS$-1.06
Q1 200030 Jun
EPS$0.26
Q4 199931 Mar
EPS$-0.01
Q3 199931 Dec
EPS$-0.10
Q2 199930 Sept
EPS$-0.03
Q1 199930 Jun
EPS$0.11
Q4 199831 Mar
EPS$-0.25
Q3 199831 Dec
EPS$-0.66
Q2 199830 Sept
EPS$0.06
Q1 199830 Jun
EPS$0.08
Q4 199731 Mar
EPS$0.08
Q3 199731 Dec
EPS$0.12
Q2 199730 Sept
EPS$-0.06
Q1 199730 Jun
EPS$-0.06
Q4 199631 Mar
EPS$-0.05
Q3 199631 Dec
EPS$-0.05
Q2 199630 Sept
EPS$-0.41
Q1 199630 Jun
EPS$-0.12
Q4 199531 Mar
EPS$-0.02
Q3 199531 Dec
EPS$-1.55
Q2 199530 Sept
EPS$-0.32
Q1 199530 Jun
EPS$-1.11
Q4 199431 Mar
EPS$-0.51
Q3 199431 Dec
EPS$-0.29
Q2 199430 Sept
EPS$0.88
Q1 199430 Jun
EPS$-0.56
Q4 199331 Mar
EPS$0.04
Q3 199331 Dec
EPS$0.05
Q2 199330 Sept
EPS$0.77
Q1 199330 Jun
EPS$-0.58
Q4 199231 Mar
EPS$-0.14
Q3 199231 Dec
EPS$-0.16
Q2 199230 Sept
EPS$0.32
Q1 199230 Jun
EPS$-0.34
Q4 199131 Mar
EPS$0.03
Q3 199131 Dec
EPS$0.05
Q2 199130 Sept
EPS$0.52
Q1 199130 Jun
EPS$-0.18
Q4 199031 Mar
EPS$-0.15
Q3 199031 Dec
EPS$-1.20
Q2 199030 Sept
EPS$0.48
Q1 199030 Jun
EPS$-0.37
Q4 198931 Mar
EPS$-0.65
Q3 198931 Dec
EPS$-0.83
Q2 198930 Sept
EPS$0.73
Q1 198930 Jun
EPS$0.07
Q4 198831 Mar
EPS$0.05
Q3 198831 Dec
EPS$0.22
Q2 198830 Sept
EPS$0.50
Q1 198830 Jun
EPS$0.12
Q3 198731 Dec
EPS$-0.14
Q2 198730 Sept
EPS$0.33
Q1 198730 Jun
EPS$0.12
Q4 198631 Mar
EPS$0.24
Q3 198631 Dec
EPS$0.25
Q2 198630 Sept
EPS$0.40
Q1 198630 Jun
EPS$0.07
Q4 198531 Mar
EPS$0.20
Q3 198531 Dec
EPS$0.27
Q2 198530 Sept
EPS$0.38

3 politicians traded within 30 days

Dividends

Dividend History

19 Aug 2021
Amount $0.0900
19 May 2021
Amount $0.0900
18 Feb 2021
Amount $0.0900
19 Nov 2020
Amount $0.0800
19 Aug 2020
Amount $0.0800
19 May 2020
Amount $0.0800
20 Feb 2020
Amount $0.0800

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about RXN

Which members of Congress have traded RXN?
1 member of Congress has disclosed 4 trade in RXN (RXN) under the STOCK Act: Gilbert Cisneros.
When was RXN most recently disclosed by Congress?
The most recent RXN disclosure was a sale by Gilbert Cisneros on 22 July 2020.
What is the total disclosed congressional trading volume for RXN?
Members of Congress have disclosed approximately $16K in RXN purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in RXN?
This RXN page updates as soon as new STOCK Act disclosures are filed for RXN. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.